Musculoskeletal Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

New Drug Product: Vimizim

Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome).

Demystifying Rheumatic Disorders

Selecting appropriate lab tests when evaluating persons with symptoms suggesting a rheumatic condition often requires a bit of detective work.

Magnet Therapy for Muscle Pain

When a magnet is placed on the skin, capillary walls relax, allowing for increased blood flow and oxygenation and pain reduction.

New Drug Product: Otrexup

Management of adults with severe, active rheumatoid arthritis (RA) or children with active polyarticular juvenile idiopathic arthritis (pJIA).

Generic Evista Tablets Approved

Teva announced the approval of Raloxifene Tablets, the generic version of Eli Lilly's Evista.

A Trend Without Sole

With the increasing popularity of minimalist footwear and barefoot running, clinicians must understand the potential implications.

Antirheumatic Indications: NSAIDs

Review this chart for quick information when you need it.

Coupons and Patient Assistance

Pass along free prescription and OTC drug coupons, vouchers, and rebates to help reduce your patients' healthcare costs.

News

Otrexup Results Published for Rhuematoid Arthritis

Antares Pharma announced the publication of results from its crossover study comparing the relative bioavailability, safety, and tolerability of Otrexup (methotrexate) to oral methotrexate (MTX) in adults with rheumatoid arthritis in the Annals of the Rheumatic Diseases.

Evidence of Short-Term Opioid Use in Low Back Pain

There is evidence of short-term efficacy (moderate for pain and small for function) of opioids for treatment of chronic low back pain (CLBP) compared with placebo; however, the effectiveness and safety of long-term opioid therapy for treatment of CLBP remains unproven.

Chinese Herb Found Effective in Active RA

Herbal Tripterygium wilfordii Hook F (TwHF) is effective for the treatment of active rheumatoid arthritis (RA) in disease-modifying antirheumatic drug-naive patients.

Lannett Launches Generic Diazepam Intensol

Lannett Company announced it has received FDA approval for its Abbreviated New Drug Application (ANDA) for Diazepam Oral Solution (Concentrate), the generic of Roxane's Diazepam Intensol.

Featured courses from mycme

Domestic Violence 3 Hour: Focus on Child Abuse for Kentucky Health ProfessionalsExternal web site

This course defines domestic violence as family violence, and further differentiates the categories of intimate ...

CE 3.00 Credits

Domestic Violence 3 Hour: Focus on Child Abuse for Florida Health ProfessionalsExternal web site

This course defines domestic violence as family violence, and further differentiates the categories of intimate ...

CE 3.00 Credits
More myCME courses »

Sign Up for Free e-newsletters